C
Pfizer Inc. PFE
$24.86 $0.291.18% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/29/2025 03/30/2025 12/31/2024 09/29/2024 06/30/2024
Revenue 13.54% 11.65% 6.84% -12.76% -28.30%
Total Other Revenue -- -- -- -55.35% -55.39%
Total Revenue 13.54% 11.65% 6.84% -12.76% -28.31%
Cost of Revenue 5.91% -0.66% -7.72% -55.19% -32.39%
Gross Profit 16.51% 16.61% 13.04% 13.04% -26.58%
SG&A Expenses -0.64% 2.87% 6.57% 4.24% 5.59%
Depreciation & Amortization 0.63% 5.08% 11.68% 12.99% 19.36%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 0.98% 0.88% 0.50% -25.29% -12.80%
Operating Income 68.01% 59.12% 30.71% 39.07% -59.53%
Income Before Tax 353.01% 512.40% 658.32% -62.52% -118.28%
Income Tax Expenses 85.31% 66.82% 97.49% -346.67% -230.08%
Earnings from Continuing Operations 520.13% 3,208.66% 270.50% -59.02% -111.90%
Earnings from Discontinued Operations 1,300.00% 176.19% 173.33% -269.23% 90.00%
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -33.33% 14.71% 20.51% 15.79% 36.17%
Net Income 514.34% 2,651.13% 279.00% -59.44% -112.09%
EBIT 68.01% 59.12% 30.71% 39.07% -59.53%
EBITDA 42.14% 38.37% 24.39% 30.86% -45.78%
EPS Basic 511.31% 2,595.87% 275.63% -59.80% -112.06%
Normalized Basic EPS 60.70% 41.73% 4.91% 15.23% -64.73%
EPS Diluted 504.53% 2,229.80% 297.64% -59.43% -112.44%
Normalized Diluted EPS 60.45% 41.71% 5.43% 17.12% -64.22%
Average Basic Shares Outstanding 0.34% 0.35% 0.37% 0.43% 0.51%
Average Diluted Shares Outstanding 0.61% 0.49% 0.30% -0.37% -0.94%
Dividend Per Share 2.41% 2.42% 2.44% 2.45% 2.47%
Payout Ratio 1.19% 1.04% -0.73% 1.54% -9.52%